Myriocin enhances the antifungal activity of fluconazole by blocking the membrane localization of the efflux pump Cdr1
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Introduction: Extrusion of azoles from the cell, mediated by an efflux pump Cdr1, is one of the most frequently used strategies for developing azole resistance in pathogenic fungi. The efflux pump Cdr1 is predominantly localized in lipid rafts within the plasma membrane, and its localization is sensitive to changes in the composition of lipid rafts. Our previous study found that the calcineurin signal pathway is important in transferring sphingolipids from the inner to the outer membrane. Methods: We investigated multiple factors that enhance the antifungal activity of fluconazole (FLC) using minimum inhibitory concentration (MIC) assays and disk diffusion assays. We studied the mechanism of action of myriocin through qRT-PCR analysis and confocal microscopy analysis. We tested whether myriocin enhanced the antifungal activity of FLC and held therapeutic potential using a mouse infection model. Results: We found that this signal pathway has no function in the activity of Cdr1. We found that inhibiting sphingolipid biosynthesis by myriocin remarkably increased the antifungal activity of FLC with a broad antifungal spectrum and held therapeutic potential. We further found that myriocin potently enhances the antifungal activity of FLC against C. albicans by blocking membrane localization of the Cdr1 rather than repressing the expression of Cdr1. In addition, we found that myriocin enhanced the antifungal activity of FLC and held therapeutic potential. Discussion: Our study demonstrated that blocking the membrane location and inactivating Cdr1 by inhibiting sphingolipids biogenesis is beneficial for enhancing the antifungal activity of azoles against azole-resistant C. albicans due to Cdr1 activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698
Noble, S. M., & Johnson, A. D. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.2.298-309.2005 · Cited by 592 · cited 13×
“(C) The MIC values of FLC of the SN152 strain and the PADH1-CDR1 mutant in a YPD medium without or with 1 μg/ml cyclosporin Awere tested by the brothmicrodilution assays (at 30°C for 48 h) (Left).”
MethodInfluentialHsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin
Singh, S. D., Robbins, N., Zaas, A. K., Schell, W. A., Perfect, J. R., & Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000532 · Cited by 362 · cited 1×
“Hsp90 is an important molecular chaperone that regulates fungal drug resistance via physically interacts with the catalytic subunit of calcineurin and Mkc1 and maintains their stable conformations (Cowen, 2009; Singh et al., 2009; LaFayette et al., 2010).”
BackgroundSanglard, D., Ischer, F., Marchetti, O., Entenza, J., & Bille, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03495.x · Cited by 350
Calcineurin inhibitors: 40 years later, can’t live without
Azzi, J. R., Sayegh, M. H., & Mallat, S. G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1390055 · Cited by 337 · cited 1×
“Tacrolimus binds to an FK506-binding protein (FKBP12) and inhibits calcineurin, and targets of rapamycin complex 1 (TORC1), which is important for ribosome biosynthesis (Azzi et al., 2013; Kasahara, 2021).”
BackgroundLaFayette, S. L., Collins, C., Zaas, A. K., Schell, W. A., Betancourt-Quiroz, M., Gunatilaka, A. A. L., Perfect, J. R., & Cowen, L. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001069 · Cited by 329 · cited 3×
“Hsp90 is an important molecular chaperone that regulates fungal drug resistance via physically interacts with the catalytic subunit of calcineurin and Mkc1 and maintains their stable conformations (Cowen, 2009; Singh et al., 2009; LaFayette et al., 2010).”
BackgroundRosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270 · cited 2×
“albicans to FLC, disk diffusion assays showed noticeable growth of cells in the zone of inhibition of 25 μg FLC on YPD plates incubated at 30°C for 48 h for SN152, crz1Δ/crz1Δ null mutant, and rta2Δ/ rta2Δ null mutant (Figure 1B) (Rosenberg et al., 2018).”
BackgroundMethodCarolus, H., Pierson, S., Muñoz, J. F., Subotić, A., Cruz, R. B., Cuomo, C. A., & Van Dijck, P. (2021) · mBio · doi:10.1128/mbio.03333-20 · Cited by 211 · cited 1×
“auris (Carolus et al., 2021), Candida lusitaniae (Borgeat et al.”
Kim, S. H., Iyer, K. R., Pardeshi, L., Muñoz, J. F., Robbins, N., Cuomo, C. A., Wong, K. H., & Cowen, L. E. (2019) · mBio · doi:10.1128/mbio.02529-18 · Cited by 136
Functional Characterization of Candida albicans ABC Transporter Cdr1p
Shukla, S., Saini, P., Smriti, Jha, S., Ambudkar, S. V., & Prasad, R. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.6.1361-1375.2003 · Cited by 135 · cited 1×
“, 2018) (Supplementary Figure S5A) and Pma1 (a marker protein of lipid rafts) (Shukla et al., 2003) with a YFP tag (Gola et al.”
Background
Cited by
Feng, Y., Lu, H., Whiteway, M., & Jiang, Y. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.10.019 · Cited by 40
Self-citationMechanisms of Azole Potentiation: Insights from Drug Repurposing Approaches
Xiong, J., Lu, H., & Jiang, Y. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00657 · Cited by 20
Self-citationZhen, C., Wang, L., Feng, Y., Whiteway, M., Hang, S., Yu, J., Lu, H., & Jiang, Y. (2024) · Advanced Science · doi:10.1002/advs.202406473 · Cited by 16
Self-citationXiong, J., Wang, L., Feng, Y., Zhen, C., Hang, S., Yu, J., Lu, H., & Jiang, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122699 · Cited by 15
Self-citationXiong, J., Wang, L., Feng, Z., Hang, S., Yu, J., Feng, Y., Lu, H., & Jiang, Y. (2024) · Antioxidants · doi:10.3390/antiox13020223 · Cited by 14
“The methodology for total RNA extraction and qRT-PCR was conducted according to the procedures described in a previous study [24].”
MethodSelf-citation
Metadata
- Authors
- Wang, H., Ji, Z., Feng, Y., Yan, T., Cao, Y., Lu, H., & Jiang, Y.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2022-12-21
- Volume
- 13
- Pages
- 1101553-1101553
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W4313461288
- Cited by
- 30
- References
- 20
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myriocin enhances the antifungal activity of fluconazole by blocking the membrane localization of the efflux pump Cdr1. https://app.cochat.ai/papers/10.3389/fphar.2022.1101553
- The paper
- Wang, H., Ji, Z., Feng, Y., Yan, T., Cao, Y., Lu, H., & Jiang, Y. (2022). Myriocin enhances the antifungal activity of fluconazole by blocking the membrane localization of the efflux pump Cdr1. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2022.1101553
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.